Blog
Health & Fitness Stocks Positioned for Strong 2025 Growth
An updated edition of the June 27, 2025, article.The health and fitness industry has grown from a niche interest into a powerhouse market, driven by a cultural shift toward healthier living. People
Is Cisco Systems (CSCO) a 'Buy' Ahead of Its Upcoming Earnings Announcement?
Tech heavyweight Cisco Systems CSCO is set to report fiscal Q4 earnings results on Wednesday after the closing bell. Cisco, a Zacks Rank #2 (Buy), has handily outperformed the market year-to-date
Realty Income vs. Simon Property: Which REIT Wins the Dividend Battle?
Income-focused investors often look to real estate investment trusts (REITs) for steady and growing dividend streams. Two of the largest and most prominent names in the sector — Realty Income
Costco (COST) Is Considered a Good Investment by Brokers: Is That True?
The recommendations of Wall Street analysts are often relied on by investors when deciding whether to buy, sell, or hold a stock. Media reports about these brokerage-firm-employed (or sell-side)
Is It Worth Investing in Analog Devices (ADI) Based on Wall Street's Bullish Views?
When deciding whether to buy, sell, or hold a stock, investors often rely on analyst recommendations. Media reports about rating changes by these brokerage-firm-employed (or sell-side) analysts
Wall Street Bulls Look Optimistic About Camtek (CAMT): Should You Buy?
When deciding whether to buy, sell, or hold a stock, investors often rely on analyst recommendations. Media reports about rating changes by these brokerage-firm-employed (or sell-side) analysts
Schlumberger (SLB) Is Considered a Good Investment by Brokers: Is That True?
Investors often turn to recommendations made by Wall Street analysts before making a Buy, Sell, or Hold decision about a stock. While media reports about rating changes by these brokerage-firm
Vertiv (VRT) Is Considered a Good Investment by Brokers: Is That True?
The recommendations of Wall Street analysts are often relied on by investors when deciding whether to buy, sell, or hold a stock. Media reports about these brokerage-firm-employed (or sell-side)
Is It Worth Investing in Micron (MU) Based on Wall Street's Bullish Views?
When deciding whether to buy, sell, or hold a stock, investors often rely on analyst recommendations. Media reports about rating changes by these brokerage-firm-employed (or sell-side) analysts
Is SkyWest (SKYW) a Buy as Wall Street Analysts Look Optimistic?
When deciding whether to buy, sell, or hold a stock, investors often rely on analyst recommendations. Media reports about rating changes by these brokerage-firm-employed (or sell-side) analysts
Is Citigroup (C) a Buy as Wall Street Analysts Look Optimistic?
The recommendations of Wall Street analysts are often relied on by investors when deciding whether to buy, sell, or hold a stock. Media reports about these brokerage-firm-employed (or sell-side)
New to Investing? This 1 Computer and Technology Stock Could Be the Perfect Starting Point
Here at Zacks, we offer our members many different opportunities to take full advantage of the stock market, as well as how to invest in ways that lead to long-term success.
The Zacks Premium
Dun & Bradstreet (DNB) Q2 Earnings: Taking a Look at Key Metrics Versus Estimates
Dun & Bradstreet (DNB) reported $585.2 million in revenue for the quarter ended June 2025, representing a year-over-year increase of 1.6%. EPS of $0.19 for the same period compares to $0.23 a year
TransMedics (TMDX) Recently Broke Out Above the 50-Day Moving Average
TransMedics (TMDX) is looking like an interesting pick from a technical perspective, as the company reached a key level of support. Recently, TMDX broke out above the 50-day moving average
Is Tutor Perini (TPC) a Buy as Wall Street Analysts Look Optimistic?
The recommendations of Wall Street analysts are often relied on by investors when deciding whether to buy, sell, or hold a stock. Media reports about these brokerage-firm-employed (or sell-side)
Wall Street Analysts Think e.l.f. Beauty (ELF) Is a Good Investment: Is It?
The recommendations of Wall Street analysts are often relied on by investors when deciding whether to buy, sell, or hold a stock. Media reports about these brokerage-firm-employed (or sell-side)
Here's What Investors Should Expect From RADCOM's Q2 Earnings
RADCOM Ltd. (RDCM) is slated to report second-quarter 2025 results on Aug. 13, before market open.
The Zacks Consensus Estimate for revenues is $17 million, suggesting 14.9% growth from the
Reasons to Include Curtiss-Wright Stock in Your Portfolio Right Now
Curtiss-Wright Corp. CW benefits from rising commercial nuclear aftermarket sales and consistent shareholder-focused initiatives that have played a pivotal role in strengthening the company’s
Green Dot's Earnings and Revenues Surpass Estimates in Q2
Green Dot Corporation GDOT reported impressive second-quarter 2025 results, wherein both earnings and revenues beat the Zacks Consensus Estimate.
Quarterly earnings per share (excluding $1.25 from
International Markets and Lam Research (LRCX): A Deep Dive for Investors
Have you evaluated the performance of Lam Research's (LRCX) international operations during the quarter that concluded in June 2025? Considering the extensive worldwide presence of this
Xeris Biopharma Holdings, Inc. (XERS) Hits Fresh High: Is There Still Room to Run?
Have you been paying attention to shares of Xeris Biopharma (XERS)? Shares have been on the move with the stock up 32.4% over the past month. The stock hit a new 52-week high of $7.61 in the
Deciphering MKS (MKSI) International Revenue Trends
Have you assessed how the international operations of MKS (MKSI) performed in the quarter ended June 2025? For this maker of analysis and processing equipment for semiconductor companies, possessing
Watts Water (WTS) International Revenue Performance Explored
Have you evaluated the performance of Watts Water's (WTS) international operations during the quarter that concluded in June 2025? Considering the extensive worldwide presence of this maker of
Puma Biotechnology, Inc. (PBYI) Soars to 52-Week High, Time to Cash Out?
A strong stock as of late has been Puma Biotech (PBYI). Shares have been marching higher, with the stock up 40.6% over the past month. The stock hit a new 52-week high of $5.06 in the previous
Improve Your Retirement Income with These 3 Top-Ranked Dividend Stocks
Strange but true: seniors fear death less than running out of money in retirement.
Also, retirees who have constructed a nest egg have valid justifications to be concerned, since the traditional


